Pharmaceutical

Enveda raises $130m to advance AI-driven plant based drug development

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.

Nov 23, 2024 - 06:00
Enveda raises $130m to advance AI-driven plant based drug development
The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.
Read the original article

Tags:

Previous Article

Europe’s TCR immunotherapy licensing deals surge 123% above US in 2024

Next Article

Amneal files again for FDA approval of first dihydroergotamine autoinjector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

ARTHEx Biotech raises funds to advance DM1 therapy to clinical trial

ARTHEx Biotech raises funds to advance DM1 therapy to c...

May 4, 2023

1910 Genetics and Microsoft partner to enhance pharmaceutical R&D

1910 Genetics and Microsoft partner to enhance pharmace...

Mar 1, 2024

AI and stable funding environments are catalysts for biotech assets

AI and stable funding environments are catalysts for bi...

Jun 28, 2024